June Sherie Almenoff - 01 Nov 2024 Form 3 Insider Report for Actinium Pharmaceuticals, Inc. (ATNM)

Role
Director
Signature
/s/ June Almenoff
Issuer symbol
ATNM
Transactions as of
01 Nov 2024
Net transactions value
$0
Form type
3
Filing time
05 Nov 2024, 17:10:15 UTC
Previous filing
14 Aug 2024
Next filing
14 Nov 2024

No securities are beneficially owned.